Gynecologic Oncology Program
There are certain types of cancer that develop only in the female reproductive system, which includes the uterus, fallopian tubes, ovaries, cervix, vagina and vulva. Collectively known as gynecologic cancer, these tumors exclusively affect women. As such, refined expertise is required to accurately diagnose and effectively treat gynecologic cancer.
What is gynecological oncology?
A subspecialty field of obstetrics and gynecology, gynecologic oncology is a medical discipline that focuses entirely on the diagnosis and treatment of gynecologic cancer as well as complex noncancerous conditions affecting the female reproductive system. As specialists in their field, gynecologic oncologists work closely with other physicians to ensure fully integrated care. Most gynecologic oncologists are fellowship-trained surgeons who are also medical oncologists that can order chemotherapy.
A trusted name in gynecologic oncology
Dedicated to providing accurate diagnoses and comprehensive treatment services, Moffitt Cancer Center is a widely known and trusted name in gynecologic oncology. Many referring physicians confidently entrust the care of their gynecologic cancer patients to our renowned Gynecologic Oncology Program.
The multispecialty team at Moffitt includes gynecologic oncologists, pathologists, radiologists, radiation oncologists, nurses and supportive care specialists. We believe collaboration among these specialists is the key to delivering the most effective patient care. As such, our entire team comes together during weekly tumor board meetings to share insights and review complex cases. We regularly communicate our findings and continually coordinate with our patients’ local physicians to make the process of planning for surgery, chemotherapy or radiation treatment as seamless as possible for our shared patients.
Types of cases we accept
Moffitt’s advanced and comprehensive Gynecologic Oncology Program accepts referrals of women of all ages with:
- A confirmed or suspected diagnosis of endometrial/uterine cancer, ovarian cancer, cervical cancer, vaginal cancer, vulvar cancer, germ cell tumors or gynecologic sarcoma
- A confirmed or suspected diagnosis of a precancerous condition affecting the cervix, vulva or vagina
- A confirmed or suspected diagnosis of gestational trophoblastic disease
- Elevated tumor markers that require further diagnostic testing
- An elevated risk of developing gynecologic cancer that warrants risk counseling and screening services due to a known genetic mutation such as BRCA1, diethylstilbestrol (DES) exposure, obesity, a prior cancer diagnosis or a family history of ovarian, uterine, breast or colon cancer
Our wide-ranging services
Moffitt offers the latest options in diagnostic imaging, laboratory testing and genetic screening, as well as innovations in surgery, chemotherapy, radiation therapy and hormone therapy. Minimally invasive and fertility-sparing approaches are highlights of our Gynecologic Oncology Program, as we understand the importance of family planning and organ preservation to our patients.
Through our robust clinical trials program, our patients also have unique opportunities to benefit from promising new treatments before those options are made widely available in other settings. Recently completed phase 2 and 3 trials have investigated topics such as intraoperative imaging, immunotherapy and chemotherapy combinations for platinum-resistant TP53-mutated epithelial cancers. For information about the clinical trials currently underway at Moffitt, contact us at 1-813-745-6100 or 1-800-679-0775 (toll-free) or complete and submit a clinical trials inquiry form online.
Comprehensive care for our shared patients
No matter what type of therapy your patient pursues at Moffitt, our multispecialty team will continually monitor her progress and adjust her treatment plan as necessary to ensure the best possible outcome and quality of life. For the convenience of our patients and their referring physicians, all of our gynecologic oncology services are available through a single program. Additionally, we prioritize short referral times to ensure that our patients can promptly receive the care they need and deserve.